Prevalence and audiological features in carriers of GJB2 mutations, c.35delG and c.101T>C (p.M34T), in a UK population study

BMJ Open

Volumn 2, Issue 4, 2012, Pages

  Hall, Amanda ^a   Pembrey, Marcus ^a   Lutman, Mark ^b   Steer, Colin ^a   Bitner Glindzicz, Maria ^c  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 26;

ARTICLE; AUDIOLOGY; AUDITORY THRESHOLD; BLOOD SAMPLING; CHILD; CLINICAL FEATURE; ETHNICITY; FEMALE; GENE DELETION; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HEARING DISORDER; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; OTOACOUSTIC EMISSION; POPULATION RESEARCH; PREVALENCE; PROSPECTIVE STUDY; SCHOOL CHILD; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM;

EID: 84865127883     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2012-001238     Document Type: Article

References (37)

1. Kelsell DP, Dunlop J, Stevens HP, et al. Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature 1997;387:80-3. (Pubitemid 27202653)
2. Kikuchi T, Kimura RS, Paul DL, et al. Gap junction systems in the mammalian cochlea. Brain Res Brain Res Rev 2000;32:163-6. (Pubitemid 30177319)
3. Zelante L, Gasparini P, Estivill X, et al. Connexin26 mutations associated with the most common form of non-syndromic neurosensory autosomal recessive deafness (DFNB1) in Mediterraneans. Hum Mol Genet 1997;6:1605-9. (Pubitemid 27397040)
4. Estivill X, Fortina P, Surrey S, et al. Connexin-26 mutations in sporadic and inherited sensorineural deafness. Lancet 1998;351:394-8. (Pubitemid 28064162)
5. Mahdieh N, Rabbani B. Statistical study of 35delG mutation of GJB2 gene: a meta-analysis of carrier frequency. Int J Audiol 2009;48:363-70.
6. Gasparini P, Rabionet R, Barbujani G, et al. High carrier frequency of the 35delG deafness mutation in European populations. Genetic Analysis Consortium of GJB2 35delG. Eur J Hum Genet 2000;8:19-23. (Pubitemid 30113791)
7. Common JE, Di WL, Davies D, et al. Further evidence for heterozygote advantage of GJB2 deafness mutations: a link with cell survival. J Med Genet 2004;41:573-5. (Pubitemid 38932120)
8. D'Adamo P, Guerci VI, Fabretto A, et al. Does epidermal thickening explain GJB2 high carrier frequency and heterozygote advantage? Eur J Hum Genet 2009;17:284-6.
9. Green GE, Scott DA, McDonald JM, et al. Carrier rates in the Midwestern United States for GJB2 mutations causing inherited deafness. JAMA 1999;281:2211-16. (Pubitemid 29275704)
10. Houseman MJ, Ellis LA, Pagnamenta A, et al. Genetic analysis of the connexin-26 M34T variant: identification of genotype M34T/M34T segregating with mild-moderate non-syndromic sensorineural hearing loss. J Med Genet 2001;38:20-5. (Pubitemid 32102318)
11. Pollak A, Skorka A, Mueller-Malesinska M, et al. M34T and V37I mutations in GJB2 associated hearing impairment: evidence for pathogenicity and reduced penetrance. Am J Med Genet A 2007;143A:2534-43. (Pubitemid 350058165)
12. Kenna MA, Feldman HA, Neault MW, et al. Audiologic phenotype and progression in GJB2 (Connexin 26) hearing loss. Arch Otolaryngol Head Neck Surg 2010;136:81-7.
13. Martin PE, Coleman SL, Casalotti SO, et al. Properties of connexin26 gap junctional proteins derived from mutations associated with non-syndromal heriditary deafness. Hum Mol Genet 1999;8:2369-76.
14. Thonnissen E, Rabionet R, Arbones ML, et al. Human connexin26 (GJB2) deafness mutations affect the function of gap junction channels at different levels of protein expression. Hum Genet 2002;111:190-7. (Pubitemid 36075038)
15. Bicego M, Beltramello M, Melchionda S, et al. Pathogenetic role of the deafness-related M34T mutation of Cx26. Hum Mol Genet 2006;15:2569-87. (Pubitemid 44288687)
16. White TW, Deans MR, Kelsell DP, et al. Connexin mutations in deafness. Nature 1998;394:630-1.
17. Griffith AJ. Genetic analysis of the connexin-26 M34T variant. J Med Genet 2001;38:E24.
18. Griffith AJ, Friedman TB. Auditory function and the M34T allele of connexin 26. Arch Otolaryngol Head Neck Surg 2002;128:94. (Pubitemid 34052100)
19. Feldmann D, Denoyelle F, Loundon N, et al. Clinical evidence of the nonpathogenic nature of the M34T variant in the connexin 26 gene. Eur J Hum Genet 2004;12:279-84. (Pubitemid 38519341)
20. Snoeckx RL, Huygen PL, Feldmann D, et al. GJB2 mutations and degree of hearing loss: a multicenter study. Am J Hum Genet 2005;77:945-57. (Pubitemid 41698516)
21. Morell RJ, Kim HJ, Hood LJ, et al. Mutations in the connexin 26 gene (GJB2) among Ashkenazi Jews with nonsyndromic recessive deafness. N Engl J Med 1998;339:1500-5. (Pubitemid 28543498)
22. Engel-Yeger B, Zaaroura S, Zlotogora J, et al. The effects of a connexin 26 mutation - 35delG-on oto-acoustic emissions and brainstem evoked potentials: homozygotes and carriers. Hear Res 2002;163:93-100. (Pubitemid 34098845)
23. Engel-Yeger B, Zaaroura S, Zlotogora J, et al. Otoacoustic emissions and brainstem evoked potentials in compound carriers of connexin 26 mutations. Hear Res 2003;175:140-51.
24. Franzé A, Caravelli A, Di Leva F, et al. Audiometric evaluation of carriers of the connexin 26 mutation 35delG. Eur Arch Otorhinolaryngol 2005;262:921-4.
25. Cucci RA, Prasad S, Kelley PM, et al. The M34T allele variant of connexin 26. Genet Test 2000;4:335-44. (Pubitemid 32115323)
26. Van Eyken E, Van Laer L, Fransen E, et al. The contribution of GJB2 (Connexin 26) 35delG to age-related hearing impairment and noise-induced hearing loss. Otol Neurotol 2007;28:970-5. (Pubitemid 47511576)
27. Golding J, Pembrey M, Jones R, et al. ALSPAC - the Avon Longitudinal Study of Parents and Children I. Study methodology. Paediatr Perinat Epidemiol 2001;15:74-87. (Pubitemid 32155760)
28. Boyd R, Golding J, Macleod J, et al. Cohort profile: the 'Children of the 90s'-the index offspring of the Avon Longitudinal Study of Parents and Children. Int J Epidemiol 2012;April:1-17.
29. Jones R, Ring S, Tyfield L, et al. A new DNA resource: a DNA bank established as part of the Avon Longitudinal Study of Pregnancy and Childhood (ALSPAC). Eur J Hum Genet 2000;8:653-60.
30. International Organisation for Standardisation (ISO). Acoustics: reference zero for the calibration of audiometric equipment, Part 1: reference equivalent threshold sound pressure levels for pure tones and supra-aural earphones. ISO 1998;389:1. Geneva: ISO.
31. British Society of Audiology Recommended Procedure. Pure tone air and bone conduction threshold audiometry with and without masking and determination of uncomfortable loudness levels. 2004.
32. Lapsley Miller JA, Marshall L, Heller LM. A longitudinal study of changes in evoked otoacoustic emissions and pure-tone thresholds as measured in a hearing conservation program. Int J Audol 2004;43:307-22. (Pubitemid 38821608)
33. Teek R, Kruustük K, Zordania R, et al. Prevalence of c.35delG and p.M34T mutations in the GJB2 gene in Estonia. Int J Pediatr Otorhinolaryngol 2010;74:1007-12.
34. Avan P, Elbez M, Bonfils P. Click-evoked otoacoustic emissions and the influence of high-frequency hearing losses in humans. J Acoust Soc Am 1997;101:2771-7.
35. Murnane OD, Kelly JK. The effects of high-frequency hearing loss on low-frequency components of the click-evoked otoacoustic emission. J Am Acad Audiol 2003;14:525-33.
36. Groh D, Pelanova J, Jilek M, et al. Changes in otoacoustic emissions and high-frequency hearing thresholds in children and adolescents. Hear Res 2006;212:90-8. (Pubitemid 43254940)
37. Young AF, Powers JR, Bell SL. Attrition in longitudinal studies: who do you lose? Aust NZ J Public Health 2006;30:353-61. (Pubitemid 44339949)